Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE

ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE

Standard Dose
712.8MG;60MG;32MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE is listed in Drugs@FDA under application 040701 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE Form and strength TABLET;ORAL - 712.8MG;60MG;32MG Sponsor BOCA PHARMA LLC Submission history Latest submission status date: 2007-04-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE is listed in Drugs@FDA under application 040701 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE Form and strength TABLET;ORAL - 712.8MG;60MG;32MG Sponsor BOCA PHARMA LLC Submission history Latest submission status date: 2007-04-03 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.